Management of Pulmonary Embolism with Stable Lower Gastrointestinal Bleeding

Initial Risk Stratification and Admission Decision

The British Thoracic Society recommends hospital admission for patients with pulmonary embolism (PE) and stable lower gastrointestinal bleeding (GIB), as active bleeding or recent major bleeding risk is an absolute contraindication to outpatient PE management, regardless of PE severity 1, 2
Patients with PE and stable lower GIB require simultaneous management of both conditions in a hospital setting, due to the risk of bleeding or decompensation 1

The American College of Chest Physicians suggests initiating therapeutic anticoagulation with unfractionated heparin (UFH) intravenously, rather than low molecular weight heparin (LMWH) or direct oral anticoagulants (DOACs), in patients with PE and GIB, due to its short half-life and ease of reversal 1, 3
The standard UFH dosing is 80 units/kg IV bolus followed by continuous infusion with aPTT monitoring, to maintain therapeutic anticoagulation while minimizing bleeding risk 4, 5

The Gut society recommends stratifying the GIB as major or minor using the Oakland score, with stable bleeds having a score ≤8 considered minor 3
Major bleeds require colonoscopy within 24 hours after adequate bowel preparation, to identify and treat the source of bleeding 3
Restrictive red blood cell transfusion thresholds should be used, with a hemoglobin trigger of 70 g/L and target of 70-90 g/L after transfusion, to minimize the risk of transfusion-related complications 3

Patients with PE and GIB should be monitored closely for hemodynamic instability, active bleeding signs, and aPTT levels, to quickly identify and respond to any changes in their condition 1, 3, 6

If the GIB becomes unstable, anticoagulation should be stopped temporarily and protamine reversal of UFH considered, to minimize the risk of further bleeding 1
CT angiography should be performed to localize the bleeding source, followed by catheter angiography with embolization if necessary, to quickly and effectively control the bleeding 3

Once the GIB is controlled and colonoscopy has identified/treated the source, patients can be transitioned to oral anticoagulation after 48-72 hours of GIB stability, to minimize the risk of recurrent PE 3
A direct oral anticoagulant (DOAC) such as apixaban or rivaroxaban may be considered as first-line for long-term PE treatment, due to its efficacy and safety profile 1, 7